Wei Hua, MSc, MHS, MD, PhD

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Initiation of Atenolol versus Methyldopa During Pregnancy and the Risk of Intrauterine Growth Restriction/small for Gestational Age

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST

• Characteristics and Medication Use Patterns of Pregnancies with COVID-19 in the Sentinel System

  Friday, August 26, 2022
  2:45 PM – 3:00 PM CEST

• Development and Validation of Claims-based Algorithms for Estimating Gestational Age of Spontaneous Abortion and Termination

  Sunday, August 28, 2022
  8:45 AM – 9:00 AM CEST